Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
enVVeno Medical Corporation
NVNO | US
12.11
USD1.33
12.30%
NVNO | US
About enVVeno Medical Corporation
Sector
Healthcare
Industry
Medical Devices
Earnings date
30/06/2024
As of date
05/03/2026
Close
12.11
Open
10.40
High
12.85
Low
10.40
enVVeno Medical Corporation a clinical med-tech company focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve a surgical implant being developed for the treatment of chronic venous disease. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine California.
View LessNVNO | US
Risk
118.2
Sharpe
-0.77
Luna's Score
49/100
Recommendation
Hold
Luna says (NVNO | US)
What's Working
Strength based on increasing price with high volume
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
What's not Working
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
125.2%1 month
118.2%3 months
107.9%6 months
109.3%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
1.52
Debt to equity
0.03
Debt to assets
0.03
Ent. to EBITDA
-0.87
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-22.37M
MarketCap
212.39M
MarketCap(USD)
212.39M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-61.28
Short ratio
4.16
Short perc.
4.36
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
3.52
Range1M
4.18
Range3M
12.55
Volumes: Market Activity
Rel. volume
1.01
Price X volume
233.73K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.87 | - | Cheaper |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | 30.41 | - |
| Price to Book | 1.52 | 6.21 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 107.90 | - | Riskier |
| Debt to Equity | 0.03 | -145.53 | Expensive |
| Debt to Assets | 0.03 | 0.35 | Cheaper |
| Market Cap | 212.39M | - | Emerging |
